...
首页> 外文期刊>PLoS Genetics >Genetic Variants Modulating CRIPTO Serum Levels Identified by Genome-Wide Association Study in Cilento Isolates
【24h】

Genetic Variants Modulating CRIPTO Serum Levels Identified by Genome-Wide Association Study in Cilento Isolates

机译:通过基因组广泛的关联研究在西仑托分离物中鉴定出调节CRIPTO血清水平的遗传变异。

获取原文
           

摘要

Cripto, the founding member of the EGF-CFC genes, plays an essential role in embryo development and is involved in cancer progression. Cripto is a GPI-anchored protein that can interact with various components of multiple signaling pathways, such as TGF-β, Wnt and MAPK, driving different processes, among them epithelial-mesenchymal transition, cell proliferation, and stem cell renewal. Cripto protein can also be cleaved and released outside the cell in a soluble and still active form. Cripto is not significantly expressed in adult somatic tissues and its re-expression has been observed associated to pathological conditions, mainly cancer. Accordingly, CRIPTO has been detected at very low levels in the plasma of healthy volunteers, whereas its levels are significantly higher in patients with breast, colon or glioblastoma tumors. These data suggest that CRIPTO levels in human plasma or serum may have clinical significance. However, very little is known about the variability of serum levels of CRIPTO at a population level and the genetic contribution underlying this variability remains unknown. Here, we report the first genome-wide association study of CRIPTO serum levels in isolated populations (n = 1,054) from Cilento area in South Italy. The most associated SNPs (p-value<5*10-8) were all located on chromosome 3p22.1-3p21.3, in the CRIPTO gene region. Overall six CRIPTO associated loci were replicated in an independent sample (n = 535). Pathway analysis identified a main network including two other genes, besides CRIPTO, in the associated regions, involved in cell movement and proliferation. The replicated loci explain more than 87% of the CRIPTO variance, with 85% explained by the most associated SNP. Moreover, the functional analysis of the main associated locus identified a causal variant in the 5’UTR of CRIPTO gene which is able to strongly modulate CRIPTO expression through an AP-1-mediate transcriptional regulation.
机译:Cripto是EGF-CFC基因的创始成员,在胚胎发育中起着至关重要的作用,并参与癌症的发展。 Cripto是一种GPI锚定蛋白,可以与多种信号通路的各种成分相互作用,例如TGF-β,Wnt和MAPK,从而驱动不同的过程,其中包括上皮-间质转化,细胞增殖和干细胞更新。 Cripto蛋白也可以裂解并以可溶且仍具有活性的形式释放到细胞外。 Cripto在成人体细胞组织中未显着表达,并且已观察到其重新表达与病理状况(主要是癌症)相关。因此,已经在健康志愿者的血浆中检测到非常低的CRIPTO水平,而在患有乳腺,结肠或成胶质细胞瘤肿瘤的患者中,其水平却明显更高。这些数据表明人血浆或血清中的CRIPTO水平可能具有临床意义。然而,关于CRIPTO血清水平在人群水平上的变异性知之甚少,而这种变异性的遗传贡献仍然未知。在这里,我们报道了来自意大利南部奇伦托地区的孤立人群(n = 1,054)中CRIPTO血清水平的首次全基因组关联研究。最相关的SNP(p值<5 * 10-8)都位于CRIPTO基因区域的3p22.1-3p21.3染色体上。在独立样本中共复制了六个CRIPTO相关位点(n = 535)。通路分析确定了一个主要网络,该网络包括CRIPTO以外的两个其他相关区域的基因,这些基因与细胞的移动和增殖有关。复制的基因座解释了CRIPTO变异的87%以上,其中85%由最相关的SNP解释。此外,对主要相关基因座的功能分析确定了CRIPTO基因5'UTR中的因果变异体,该变异体能够通过AP-1介导的转录调控强烈调节CRIPTO表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号